Neoadjuvant Trastuzumab and Pertuzumab for Early HER2-Positive Breast Cancer: A Real World Experience. Hall BJ, Bhojwani AA, Wong H, Law A, et al. Breast J 2022;2022:7146172.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hall BJ, Bhojwani AA, Wong H, Law A, et al. Neoadjuvant Trastuzumab and Pertuzumab for Early HER2-Positive Breast Cancer: A Real World Experience. Breast J 2022;2022:7146172.
PMID: 35833190